.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Farmers Insurance
US Department of Justice
Covington
Colorcon
Chubb

Generated: September 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: mercaptopurine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
5329III10/7/1983SIGMA F AND D DIV LTD6-MERCAPTOPURINE HYDRATE AS OBTAINED FROM PHARMA-WALDHOF GmbH
9359III9/23/1991SA AJINOMOTO OMNICHEM NV6-MERCAPTOPURINE
15249AII1/15/2001FERMION OY6-MERCAPTOPURINE
16575III4/30/2003CHANGZHOU SIYAO PHARMACEUTICALS CO LTDMERCAPTOPURINE USP
16805III9/2/2003ZHEJIANG CHENG YI PHARMACEUTICAL CO LTDMERCAPTOPURINE USP
19668III8/6/2006ZHEJIANG CHENG YI PHARMACEUTICAL CO LTDMERCAPTOPURINE, USP, NON-STERILE A PHARMACEUTICAL INGREDIENT
21267III1/22/2008BENZOCHEM LIFESCIENCES PVT LTDMERCAPTOPURINE USP
21758III7/1/2008RPG LIFE SCIENCES LTDMERCAPTOPURINE USP
22971AII7/21/2009AARTI INDUSTRIES LTDMERCAPTOPURINE
26849AII12/30/2012ZHEJIANG CHENG YI PHARMACEUTICAL CO LTDMERCAPTOPURINE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
McKinsey
Fish and Richardson
US Department of Justice
Johnson and Johnson
Julphar
Dow
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot